Neoplasm
Not recruitingStudy on the Effects of AS01B, Ipilimumab, and Nivolumab in Patients with Advanced Melanoma
- Disease:Neoplasm
- Substances:IpilimumabNivolumab
Belgium- Participants:18–64 years · 65+ years
- Substances:Ipilimumab
- Sponsor:UZ Brussel
Rare diseases
Investigational molecules
Locations
Back to Belgium255 clinical trials in Jette, Belgium across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Clinical investigations focusing on innovative treatments for various cancers, including non-small cell lung cancer, melanoma, and colorectal cancer. Studies are evaluating new combination therapies and targeted treatments to improve patient outcomes.
Advanced clinical trials exploring immunotherapy combinations and targeted molecular approaches.
Research focusing on treatments for diabetes and obesity, including innovative therapies for both Type 1 and Type 2 diabetes. Studies are evaluating new medications for weight management and metabolic control.
Comprehensive trials investigating metabolic disease management and treatment outcomes.
Studies examining treatments for status epilepticus and Alzheimer's-related psychosis. Research includes innovative approaches to managing neurological complications following cardiac arrest.
Advanced clinical research focusing on improving neurological outcomes and patient care.
Tell us about your condition – we search every trial in Europe and connect you with the right site.